Ning Ji

Title: Innovations of Ning Ji in Bifunctional Nucleoside Hydrogel

Introduction

Ning Ji is an accomplished inventor based in Sichuan, China. He has made significant contributions to the field of biochemistry, particularly in the development of innovative hydrogels. His work focuses on creating materials that have potential applications in medicine, especially in cancer treatment.

Latest Patents

Ning Ji holds a patent for a bifunctional nucleoside hydrogel, which is a groundbreaking invention. This hydrogel is formed by dissolving isoguanosine, guanosine, and a borate in water or an aqueous solution, followed by crosslinking. The bifunctional nucleoside hydrogel serves as both a carrier and a drug, demonstrating a significant inhibitory effect on tumor cell activity. Notably, it shows remarkable efficacy against cells related to various types of cancer, including lung cancer, glioma, osteoma, colon cancer, breast cancer, oral squamous cell carcinoma, and tongue squamous cell carcinoma. The hydrogel's inhibitory effect on oral squamous cell carcinoma is particularly noteworthy, indicating its potential as a new approach for treating this type of cancer.

Career Highlights

Ning Ji is affiliated with Sichuan University, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to advancements in cancer treatment methodologies. With a patent count of 1 patent, he continues to explore new avenues in his field.

Collaborations

Ning Ji collaborates with talented individuals such as Hang Zhao and Xin Zeng, who contribute to his research efforts. Their combined expertise enhances the potential impact of their work in the field of biochemistry.

Conclusion

Ning Ji's innovative work on bifunctional nucleoside hydrogels represents a significant advancement in cancer treatment research. His contributions have the potential to lead to new therapeutic options for patients suffering from various types of cancer.